The UK government is reportedly preparing to extend Palantir’s contract for the NHS Federated Data Platform (FDP) by two years while exploring options for a future replacement. The Financial Times reported on November 5, 2026 that a government review had found an early switch could disrupt NHS services. As of November 6, no final extension decision or replacement contract had been publicly announced.
Palantir provides software for the NHS in England through the Federated Data Platform. The system helps healthcare organisations connect and analyse information held in different systems. It is designed to support hospital planning, patient care and resource management without placing all NHS patient records into one central database. The agreement has attracted attention because it involves sensitive health information and a major US technology supplier.
According to NHS England’s contract explainer, a consortium led by Palantir Technologies UK, including Accenture, PwC, NECS and Carnall Farrar, won the agreement in November 2023. The contract has a potential value of up to £330 million over seven years, rather than representing a fixed amount already paid. It began in March 2024 with an initial three-year commitment, followed by options to extend it for two years and then two additional one-year periods.
The platform is intended to help hospitals manage waiting lists, schedule operations, monitor available beds, and improve patient discharge processes. By connecting information that was previously stored in separate systems, the NHS hopes to reduce delays and help medical staff make faster decisions.
The agreement has faced growing political opposition. In July 2026, the House of Commons Health and Social Care Committee urged ministers to seek an alternative, citing concerns about public trust, patient data security and uncertainty over the platform’s reported benefits. Another parliamentary committee has warned that depending heavily on one technology supplier could make future changes more difficult and expensive.
The first major contract decision point comes in March 2027, when the initial three-year commitment ends. According to a House of Commons Library briefing, the government must notify Palantir by December 2026 if it decides not to extend the agreement. Moving to another supplier could require technical changes, staff preparation and careful coordination to avoid interrupting services at hospitals already using the platform.
Reports suggest ministers are leaning toward the available two-year extension, which would allow the existing arrangement to continue until March 2029. The additional time could help NHS England assess replacement technology and prepare a future procurement process. However, the reported plan does not mean that a new supplier has been selected or that a replacement tender has already been formally announced.
The possibility of a UK-based replacement reflects wider concerns about digital independence and reliance on foreign technology providers. Some MPs want more critical public-sector software to be developed and controlled domestically. However, in its published response to Parliament, the government said procurement must follow fair and non-discriminatory rules and cannot automatically favour a supplier because of its nationality. A British replacement therefore remains a possibility rather than a guaranteed outcome.
Patient information remains a central concern in the debate. NHS England says it and participating NHS organisations control their respective data, while Palantir acts as a data processor under their instructions. In 2026, NHS England also corrected earlier descriptions of supplier access to identifiable patient information within a specific national system. Its clarification on contractor access says authorised access is restricted and governed by security requirements. The controversy highlights wider questions about data privacy and access controls when public institutions use external technology providers.
Palantir has defended its role in the NHS, arguing that its software helps healthcare providers improve services and deliver better patient outcomes. The company maintains that its technology supports medical professionals by making important operational information easier to access and use.
The scale of the platform’s rollout also makes the decision significant. As of August 2026, 142 of England’s 202 NHS trusts were using the Federated Data Platform operationally, according to parliamentary research. NHS England has reported improvements in some areas of hospital performance, but it has acknowledged that these changes cannot automatically be attributed to the platform because other factors may have contributed. An independent evaluation was also being carried out to assess its effectiveness.
The dispute also highlights the risks of depending on a single enterprise technology provider. Replacing an established system can involve technical compatibility issues, data migration, staff training and service continuity planning. It also connects with the wider debate over sovereign cloud and data residency, where organisations must consider who controls sensitive information, who can access it and which legal rules apply.
For now, the government faces a decision between maintaining the existing platform and preparing for a possible future change of supplier. Any transition would need to protect patient services, meet data security requirements and follow public procurement rules. The reported two-year extension may provide more time for that process, but its final approval and any future replacement remain unconfirmed.
